WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Can Küçük
1,700 Points

Contributions by role

Editor 1,700

Contributions by subject area

Immunology
Oncology
Hematology
Internal Medicine
Otorhinolaryngology
Surgery and Surgical Specialties
Bioinformatics
Genomics
Gynecology and Obstetrics
Public Health
Molecular Biology
Cell Biology
Genetics
Virology
Gastroenterology and Hepatology
Infectious Diseases
Biotechnology
Medical Genetics
Clinical Trials
Women's Health
Biochemistry
Translational Medicine
Histology
Radiology and Medical Imaging
Urology
Data Mining and Machine Learning
Epidemiology
Drugs and Devices
Statistics

Can Küçük


Summary

Dr. Can Küçük currently works at Dokuz Eylül University and İzmir Biomedicine and Genome Center (IBG) in Turkey as a faculty and independent PI with his own research group. He has authored research articles in high profile journals on molecular pathobiology, genetics, or diagnostics of NK and/or T cell malignancies.

Dr. Küçük graduated from the Department of Molecular Biology and Genetics at Middle East Technical University (METU) in 2005. He got his Ph.D degree in Cancer Biology and Oncology from Eppley Institute for Research in Cancer and Allied Diseases at University of Nebraska Medical Center (UNMC) in 2012. He worked as a post-doc in the Department of Pathology at UNMC and then at City of Hope Medical Center.

His group investigates the etiology of lymphoid malignancies using personalized medicine approach. In particular, targeted sequencing, whole transcriptome sequencing, or epigenome sequencing are applied on tumor samples to identify aberrant genes or pathways leading to development of these neoplasms. His group aims to:

1) identify novel recurrent aberrations that can be targeted by rational drugs.
2) develop companion diagnostics methodologies for personalized medicine
3) identify novel biomarkers of diagnosis, prognosis or disease management.

Bioinformatics Genomics Hematology Immunology Medical Genetics Oncology Pathology Translational Medicine

Past or current institution affiliations

Dokuz Eylül University

Work details

Associate Professor

Izmir Biomedicine and Genome Center (IBG)
February 2018
Izmir Biomedicine and Genome Center (IBG)
Lymphoid Cancer Biology and Genomics

Associate Professor

Dokuz Eylül University
Medical Biology

Websites

  • Google Scholar
  • LinkedIn

PeerJ Contributions

  • Edited 12

Academic Editor on

August 5, 2020
A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma
Hao Zhou, Chang Zheng, De-Sheng Huang
https://doi.org/10.7717/peerj.9658 PubMed 32844062
June 1, 2020
Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis
Tuo Deng, Xueming Lin, Xiaolu Duan, Zihao He, Zhijian Zhao, Guohua Zeng
https://doi.org/10.7717/peerj.9282 PubMed 32547884
November 22, 2019
Lymph node detection in MR Lymphography: false positive reduction using multi-view convolutional neural networks
Oscar A. Debats, Geert J.S. Litjens, Henkjan J. Huisman
https://doi.org/10.7717/peerj.8052 PubMed 31772836
July 25, 2019
A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma
Tian Lan, Yunyan Lu, Zunqiang Xiao, Haibin Xu, Junling He, Zujian Hu, Weimin Mao
https://doi.org/10.7717/peerj.7353 PubMed 31380150
May 16, 2019
Expression of ICOSL is associated with decreased survival in invasive breast cancer
Bin Wang, Huayong Jiang, Tingyang Zhou, Ning Ma, Wei Liu, Yajie Wang, Li Zuo
https://doi.org/10.7717/peerj.6903 PubMed 31143539
April 22, 2019
Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database
Wenjuan Wu, Jing Sui, Tong Liu, Sheng Yang, Siyi Xu, Man Zhang, Shaoping Huang, Lihong Yin, Yuepu Pu, Geyu Liang
https://doi.org/10.7717/peerj.6761 PubMed 31065456
September 19, 2018
Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis
Chia-Che Wu, Shau-Hsuan Li, Hung-I Lu, Chien-Ming Lo, Yu-Ming Wang, Shang-Yu Chou, Yen-Hao Chen
https://doi.org/10.7717/peerj.5655 PubMed 30258731
March 12, 2018
Clinical impact of albumin in advanced head and neck cancer patients with free flap reconstruction—a retrospective study
Ming-Hsien Tsai, Hui-Ching Chuang, Yu-Tsai Lin, Hui Lu, Wei-Chih Chen, Fu-Min Fang, Chih-Yen Chien
https://doi.org/10.7717/peerj.4490 PubMed 29576961
December 21, 2017
Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia
Qianying Zhang, Kanchun Dai, Laixi Bi, Songfu Jiang, Yixiang Han, Kang Yu, Shenghui Zhang
https://doi.org/10.7717/peerj.4139 PubMed 29302387
December 8, 2017
Clinical significance of circulating immune cells in left- and right-sided colon cancer
Jiabo Di, Meng Zhuang, Hong Yang, Beihai Jiang, Zaozao Wang, Xiangqian Su
https://doi.org/10.7717/peerj.4153 PubMed 29230377
November 17, 2017
NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1
Lei Wang, Zhiqiang Peng, Kaizhen Wang, Yijun Qi, Ying Yang, Yue Zhang, Xinyuan An, Shudong Luo, Junfang Zheng
https://doi.org/10.7717/peerj.4065 PubMed 29158991
July 19, 2017
DAPK1 as an independent prognostic marker in liver cancer
Ling Li, Libin Guo, Qingshui Wang, Xiaolong Liu, Yongyi Zeng, Qing Wen, Shudong Zhang, Hang Fai Kwok, Yao Lin, Jingfeng Liu
https://doi.org/10.7717/peerj.3568 PubMed 28740751